Company Profile
Editas Medicine Stock Price, News & Analysis
- Ticker:
- EDIT
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Editas Medicine is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
2.76 USD (-1.43%)
Close
Last updated: June 23, 2026 at 00:00
423.55M USD
Market cap
Why the stock is moving
EDIT is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Editas Medicine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Editas Medicine is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Editas Medicine follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Editas Medicine sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Editas Medicine (EDIT)?
Editas Medicine (EDIT) most recently closed at 2.76 USD, a -1.43% move versus the previous session.
What is the market cap of Editas Medicine (EDIT)?
Editas Medicine currently has a market capitalization of 423.55M USD on BioPharmSignal.
What does Editas Medicine do?
Editas Medicine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is EDIT stock listed?
Editas Medicine (EDIT) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Editas Medicine is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Editas?
Editas Medicine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Editas Medicine targeting with Editas?
Editas Medicine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Medicine?
Editas Medicine is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.